Alivus Life Sciences Ltd

NSE: ALIVUS · BSE: 543322 · Pharmaceuticals & Biotechnology · 34 announcements

Share price: ₹1,454.90
Market cap: ₹17,891 Cr
Revenue (annual): ₹2,552 Cr
Net profit (annual): ₹564.5 Cr
P/E (TTM): 26.7×Sector 43.8×
Promoter holding: 74.85%-0.02% QoQ
FII holding: 5.93%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 7 Financial Results 5 Results Update 3 Employee Stock Options 3 Board Meeting Date 3 Other Announcement 2 Merger & Restructuring 2 Annual General Meeting 2 Acquisition 2 Promoter Selling 1 Legal & Regulatory 1 Debt & Borrowing 1 Business Update 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

14 Oct 2026 16:52 IST BSE

Other Announcement

Alivus Life Sciences Other Announcement

The company filed its quarterly shareholding pattern for the period ended September 30, 2026, as per regulatory requirements.

Open announcement → Read the filing ↗

7 May 2026 18:47 IST BSE

Other Announcement

Alivus Life Sciences Other Announcement

Alivus Life Sciences Limited filed its Annual Secretarial Compliance Report for FY2025-26. The report confirms full regulatory compliance with no adverse observations from the practicing company secretary.

Open announcement → Read the filing ↗